Skin conditions (dermatitis, eczema, psoriasis) Board decisions

The Board denied a compensable disability rating for pseudofolliculitis barbae and tinea versicolor with psoriasis affecting the left great toe prior to June 4, 2022 and from June 4, 2023. However, it granted a 10 percent disability rating for TV affecting the left great toe from June 4, 2022 to June 4, 2023.

The Board denied the veteran's claims for an increased rating for tension type headaches, a compensable rating for pseudofolliculitis barbae, and service connection for left and right elbow conditions.

The Board granted a rating of 60 percent for the skin disability, to include pseudofolliculitis barbae and tinea versicolor, effective June 21, 2022.

The Board remands the claims for an increased rating for the Veteran's left shoulder disability and tinea cruris to correct duty to assist errors.

The Board denied an initial compensable rating for chloracne, finding it did not meet the criteria for a 10 percent evaluation under DC 7829.

The Board remands the claim for a rating in excess of 10 percent for acne keloidalis nuchae to schedule an examination to assess scarring and determine if a higher rating is warranted.

The appeal of a proposed reduction in the disability rating for service-connected psoriasis from 30 percent to 0 percent was dismissed as it was not a final decision.

The Board remands the claim for service connection for pseudofolliculitis barbae to obtain a supplemental medical opinion addressing the Veteran's contentions and noted risk factors.

The Board denied the veteran's claims for increased ratings and service connection, as well as remanded several issues for further development.

The Board denied an increased rating for tinnitus and granted higher ratings for the low back disability, right and left lower extremity sciatic radiculopathy.

The Board granted service connection for GERD, to include as secondary to service-connected sarcoidosis, and denied service connection for obstructive sleep apnea and pseudofolliculitis barbae.

The Board granted a 60 percent rating for eczema based on the Veteran's need for constant or near-constant systemic therapy involving topical corticosteroids over the past year.

The Board granted service connection for bilateral metatarsalgia, plantar fasciitis, tinea pedis, right knee ACL repair with degenerative arthritis, and a 50 percent evaluation for migraine headaches.

The Board denied an earlier effective date for the award of service connection for dermatitis due to the first complete claim received within one year of the Veteran's intent to file being a Supplemental Claim rather than the later submitted VA Form 21-526EZ.

The Board denied an initial disability rating greater than 10 percent for service-connected pseudofolliculitis barbae.

The Board denied higher ratings for the Veteran's degenerative joint disease, radiculopathy of the right upper extremity, right shoulder rotator cuff tendonitis, angiolymphoid hyperplasia with eosinophilia, and pseudofolliculitis barbae.

The Board granted a 10 percent rating for bilateral tinea unguium and remanded the claims for service connection for erectile dysfunction and bilateral flatfoot.

The Board denied the Veteran's claim for an initial compensable rating for pseudofolliculitis barbae as the evidence did not show that his condition met the criteria for a compensable rating.

The Board denied service connection for allergies, bronchitis, costochondritis, and a skin condition, but granted an initial rating of 50 percent for migraines. Several claims were remanded.

The Board denied service connection for various disorders and a rating in excess of 10 percent for pseudofolliculitis barbae, as the evidence did not support the claims.